# POTELIGEO

NDC: 42747-761
Generic name: mogamulizumab-kpkc
Labeler / Manufacturer: Kyowa Kirin, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20180808

FDA application: BLA761051

## Active ingredients

- MOGAMULIZUMAB: 4 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42747-761"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42747-761
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e53960ab-42a1-40d1-9c7d-eb013fe7f18f